Hephaistos Pharma
Latest round
- Seed
Last raised
- May 2024
Total raised
- $7M
Investors
- 6
About Hephaistos Pharma
Founded in 2018 and based in Orsay, France, Hephaistos Pharma is a biopharmaceutical company that develops medicine for cancer treatment. Martine Caroff (CSO), Jean-Marc Cavaillon, Frederic Caroff (CEO), and Alexey Novikov are the co-founders of the company. The company specialized in developing immunomodulators, which strengthen the immune system to fight cancer. The firm develops immunotherapy by inducing an immunological response in the patient and converting cold tumours into targets for the immune system. The injectable immunostimulant known as the onco-boost platform from Hephaistos targets metastatic and difficult-to-reach malignancies such as osteosarcoma. This mechanism involves stimulating monocytes and dendritic cells to recruit and mature immune defenses such as CD4 T cells, CD8 T cells, and macrophages. In addition, monoclonal antibodies block the pathways by which host cells and tumour cells recognise each other, enabling the immune system to eliminate tumours. The group also has a natural adjuvant called vaxi-boost that functions as a human vaccination in its pipeline. The company’s partners include Medicen, Genopole, Leon Berard, BioAster, Pulsalys, and others.
Who invested in Hephaistos Pharma
6 investors across 2 rounds
See all investors in Hephaistos Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Hephaistos Pharma
Who invested in Hephaistos Pharma?
Hephaistos Pharma has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Hephaistos Pharma raised?
Hephaistos Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Hephaistos Pharma last raise money?
Hephaistos Pharma's most recent round on record is a Seed, in May 2024.
What does Hephaistos Pharma do?
Founded in 2018 and based in Orsay, France, Hephaistos Pharma is a biopharmaceutical company that develops medicine for cancer treatment.
Where is Hephaistos Pharma headquartered?
Hephaistos Pharma is headquartered in France.
Which VCs invest in companies like Hephaistos Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Hephaistos Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Hephaistos Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.